You are here

Home » Content

ARSENIC BODY- BURDEN IN CORONARY HEART DISEASE CASES OF WEST BENGAL, INDIA.

ARSENIC BODY- BURDEN IN CORONARY HEART DISEASE CASES OF WEST BENGAL, INDIA.

Journal Name:

  • International Journal of Medical Research & Health Sciences

Publication Year:

  • 2013

Key Words:

Author Name
Abstract (2. Language): 
Background: Coronary Heart Disease is a big concern for the health of the residents of India. Environmental contaminants, air pollutants, synthetic chemicals, and the mineral content in drinking water can affect the heart by altering the heart rate, contractility and excitability of heart muscle or by causing atherosclerosis. Objective: The aim of this study is to observe the level of arsenic exposure and clastogenic effect of arsenic in coronary heart disease cases of West Bengal. Methods: A total 511 cases were screened. Our study group included 100 nos of coronary heart disease cases and 70 no of healthy controls from West Bengal. Multivariate Logistic Regression and Student’s t - test was used for statistical analysis of the parameters. The clastogenic effect of Arsenic was also examined by performing Cytogenetic Analysis. Results: Multivariate logistic regression analysis has revealed that a patient’s age, Low density lipoprotein level and hypertension played a significant role in the development of CHD. Hair arsenic level in CHD cases (0.7±0.2) μg/kg was significantly high (p<0.01) than that of the controls (0.20±0.09) μg/kg. Mitotic index (4.4±0.21) was significantly low (p≤0. 05) and chromosomal aberration (0.61±0.13) was significantly higher (p≤0. 005) in CHD cases. Conclusion: This study has revealed the facts that age, low density lipoprotein level, hypertension are the three significant risk factors of CHD. It was found that, the hair arsenic content of the CHD cases in this region was having the arsenic body burden. Clastogenic effect of arsenic on coronary heart disease cases.
Bookmark/Search this post with
FULL TEXT (PDF): 
PDF icon arastirmax-arsenic-body-burden-coronary-heart-disease-cases-west-bengal-india.pdf
  • 1
8-18
  • Turkish

REFERENCES

References: 

1. Murray CJ, Lopez AD. Mortality by cause for
eight regions of the world: Global Burden of
Disease Study. Lancet.1997;349: 1269–76.
2. Austin MA, Hokanson JE, Edwards KL.
Hypertriglyceridemia as a cardiovascular risk
factor. Am J Cardiol.1998; 81:78-123.
3. Ted Schettler. Heart Disease and the
Environment. Science and Environmental
Health Network (May 2005).
4. Ramos K, Bowes R, Ou X, Weber T.
Responses of vascular smooth muscle cells to
toxic insult: Cellular and molecular
perspectives for environmental toxicants. J
Toxicol Environ Health. 1994;43:419-440.
5. Hansson G. Inflammation, atherosclerosis, and
coronary artery disease. New England Journal
of Medicine. 2005;352:1685-1695.
6. Engel RR, Hopenhayn RC, Receveur O, et al.
Vascular effects of chronic arsenic exposure: a
review. Epidemiol Rev.1994;16:184–209.
7. Simeonova PP, Luster MI. Arsenic and
atherosclerosis. Toxicol Appl Pharmacol.2004;
198:444–9.
8. Alissa EM, and Ferns GA. Heavy Metal
Poisoning and Cardiovascular Disease. Journal
of Toxicology, 2011;21: 20
9. Pi J, Yamauchi H, Kumagai Y, et al. Evidence
for induction of oxidative stress caused by
chronic exposure of Chinese residents to
arsenic contained in drinking water. Environ
Health Perspect. 2002;110:331–6.
10. Wu MM, Chiou HY, Wang TW, et al.
Association of blood arsenic levels with
increased reactive oxidants and decreased
antioxidant capacity in a human population of
northeastern Taiwan. Environ Health Perspect.
2001;109:1011–17.
11. Pi J, Kumagai Y, Sun G, et al. Decreased
serum concentrations of nitric oxide
metabolites among Chinese in an endemic area
of chronic arsenic poisoning in inner Mongolia.
Free Radic Biol Med. 2000;28:1137–42.
12. Pi J, Yamauchi H, Sun G, et al. Vascular
dysfunction in patients with chronic arsenosis
can be reversed by reduction of arsenic
exposure. Environ Health Perspect.
2005;113:339–41.
15
De Auley et al., Int J Med Res Health Sci. 2013:2(1);8-18
13. Lee MY, Bae ON, Chung SM, et al.
Enhancement of platelet aggregation and
thrombus formation by arsenic in drinking
water: a contributing factor to cardiovascular
disease. Toxicol Appl Pharmacol.2002;179:83–
8.
14. Kumar SV, Bhattacharya S. In vitro toxicity of
mercury, cadmium, and arsenic to platelet
aggregation: influence of adenylate cyclase and
phosphodiesterase activity. In Vitr Mol
Toxicol. 2000;13:137–44.
15. Das D, Chatterjee A, Mandal BK, Samanta
G,Chakraborti D. Arsenic in ground water in
six districts of West Bengal, India: the biggest
arsenic calamity in the world. II. Arsenic
concentration in drinking water, hair,nails,
urine, skin-scale and liver tissue (biopsy) of the
affected people. Analyst.1995;120:917-924.
16. Paul S, Chakraborty, Halder A, Bandopadhyay
D, Chaudhuri U, De M Association of
genotoxic effects of arsenic with
haematological malignancy in West Bengal.
Human and Experimental Toxicology
2011;30(2) 165-170.
17. Samanta G, Sharma R, Roychowdhury T,
Chakraborti D. Arsenic and other elements in
hair, nails, and skin-scales of arsenic victims in
West Bengal, India. Science of the Total
Environment. 2004;326:33–47.
18. Yusuf S, Hawken S, Ounpuu S, Dans T,
Avezum A, Lanas F, Mc Queen M, Budaj
A, Pais P, Varigos J, Lisheng L; Interheart
Study Investigators. Effect of potentially
modifiable risk factors associated with
myocardial infarction in 52 countries (the
Interheart study): case-control study. Lancet.
2004;364:937–52.
19. Chakraborty TU. Das S. Poddar B,
Sengupta and M. De. Micronuclei and
Chromosomal Aberrations as Biomarkers: A
Study in an Arsenic Exposed Population in
West Bengal, India. Bull.
Environ.Contam.Toxicol.2006;76:970-976.
20. Rose GA, Blackburn H, Gillium FF, Prineas
RJ. Cardiovascular survey methods. WHO:
Geneva: 1982.
21. Sharma A, Talukder G Laboratory procedures
in human genetics, chromosome methodology,.
The nucleus. 1974; 1: 25-29.
22. Gupta R, Joshi P, V Mohan V, Reddy KS,
Yusuf S. Epidemiology and causation of
coronary heart disease and stroke in India.
Heart 2008; 94: 16-26.
23. Hodes RJ. International effort finds new
genetic variants associated with lipid levels,risk
for coronary artery disease. News and events
press release. International 2008;36:907-917.
24. De Suprio, Ghosh S, Chatterjee R, Chen YQ,
Moses L, Kesari A, Hoffman P, Eric, Dutta
Sisir Kr. PCB congener specific oxidative
stress response by microarry analysis using
human liver cellline. Environmental
International 2010;36:907-917.
25. Ghosh S, De Suprio, Chen YQ, Sutton DC,
Ayorinde FO, Dutta SK. Polychlorinated
biphenyls (PCB-153) and (PCB-77) absorption
in human liver (HepG2) and kidney (HK2)
cells in vitro: PCB levels and cell death.
Environment International, 2010 Vol: 36(8):
893-901.
26. Chadha SL, Gopinath N, Shekhawat S. Urbanrural
differences in the prevalence of coronary
heart disease and its risk factors in Delhi.
Bulletin of the World Health Organization
1997;75(1):31-38.
27. Kumar M, Chakravarti RN, Singh A, Wahi PL.
Serum lipid profiles in patients of myocardial
infarction in Chandigarh area (Northern India).
Atherosclerosis 1976;24: 355–361.
28. Wasir HS, Bharani AK, Bhatia ML.
Correlation of risk factors with coronary
angiographic findings in patients of ischaemic
heart disease. J Assoc Physicians India. 1987;
35: 483–487.
29. Vashist S, Narula J, Awtade A, Tandon R,
Srivastava LM. Lipids and lipoproteins in
normal controls and clinically documented
16
De Auley et al., Int J Med Res Health Sci. 2013:2(1);8-18
coronary heart disease patients. Ann Natl Acad
Med Sci 1990; 26: 57–66
30. Gupta R, Gupta VP, Sarna M, Prakash H,
Bhatnagar S. Changing trends in coronary risk
factor prevalence in an Indian urban
population. Indian Heart J 2000; 52: 746–747
31. Reddy KS, Yusuf S. Emerging epidemic of
cardiovascular disease in developing countries.
Circulation 1998; 97: 596–601.
32. Ramachandran A, Snehalatha C, Latha E,
Vijay V, Vishwanathan M. Rising prevalence
of NIDDM in an urban population in
India. Diabetologia 1997; 40: 232–237.
33. Guha Mazumder D.N. Chronic arsenic toxicity
& human health. Indian J Med Res 2008; 128,
pp 436-447.
34. Bhatnagar A. Environmental cardiology:
studying mechanistic links between pollution
and heart disease. Circ Res. 2006;99(7):692–
705.
35. Chih-Hao Wang, Jiann-Shing Jeng, Ping-
Keung Yip, Chi-Ling Chen, Lin-I Hsu, Yu-Mei
Hsueh, Hung-Yi Chiou, Meei-Mann Wu and
Chien-Jen Chen. Biological Gradient Between
Long-Term Arsenic Exposure and Carotid
Atherosclerosis. Circulation 2002;105:1804-
1809.
36. Zaldivar, R. Arsenic contamination of drinking
water and foodstuffs causing endemic chronic
arsenic poisoning. Beitr. Pathol. 1974;151:384-
400.
37. WHO. Guideline for drinking water
quality,Recommendation, Vol 1.2nd edition.
Geneva:World Health Organization,1984.
38. Gallagher, P.A.; Murray, S.; Wei, X.;
Schwegel, C.A.; Creed, J.T. An evaluation of
sample dispersion media used with accelerated
solvent extraction for the extraction and
recovery of arsenicals from LFB and DORM-2.
J. Anal. At. Spectrom. 2002; 17:581–587.
39. Squibb, K. S., Fowler, B. A. The toxicity of
arsenic and its compounds. In B. A. Fowler
(Ed.), Biological and Environmental Effects of
Arsenic. Elsevier, New York1983; pp 233-269.
40. Sanz ER. Muñoz-Olivas C. Cámara M, Kumar
Sengupta & Ahamed S. Arsenic speciation in
rice, straw, soil, hair and nails samples from
the arsenic-affected areas of Middle and Lower
Ganga plain, Journal of Environmental Science
and Health, Part A, 2007; 42(12)1695-1705.
41. Sohel N, Persson LA, RahmanM, Streatfield
PK, YunusM, Ekstrom EC,et al. Arsenic in
drinking water and adult mortality: a
population-based cohort study in rural
Bangladesh. Epidemiology 2009;20:824-30.
42. Medrano MA, Boix R, Pastor-Barriuso R,
Palau M, Damian J, Ramis R, et al. Arsenic in
public water supplies and
cardiovascularmortality in Spain. Environ Res
2010;110:448-54.
43. Chen CJ, Hsueh YM, Lai MS, Shyu MP, Chen
SY, Wu MM,et al. Increased prevalence of
hypertension and long-term arsenic exposure.
Hypertension 1995;25:53-60.
44. Rahman M, Tondel M, Ahmad SA,
Chowdhury IA, FaruqueeMH, Axelson O.
Hypertension and arsenic exposure in
Bangladesh. Hypertension 1999;33:74-8.
45. Chen CJ, Chiou HY, Chiang MH, Lin LJ, Tai
TY. Dose-response relationship between
ischemic heart diseasemortality and long-term
arsenic exposure. Arterioscler Thromb Vasc
Biol 1996;16:504-10.
46. Tseng CH, Chong CK, Tseng CP, Hsueh YM,
Chiou HY, Tseng CC,et al. Long-term arsenic
exposure and ischemic heart disease in
arseniasis-hyperendemic villages in Taiwan.
Toxicol Lett 2003;137:15-21.
47. Wang CH, Jeng JS, Yip PK, Chen CL, Hsu
LI, Hsueh YM, Chiou HY, Wu MM, Chen CJ.
Biological gradient between long-term arsenic
exposure and carotid atherosclerosis.
Circulation 2002;105(15):1804-9.
48. Gonsebatt ME, Vega L, Montero R, Guzman P,
Garcia-Vargas G, Del Razo LM, Albrores A,
Cebrian ME, Ostrosky-Wegman P.
Lymphocytes replicating ability in individuals
exposed to arsenic via drinking water. Mut
Res.1994; 313:293-299. 17
De Auley et al., Int J Med Res Health Sci. 2013:2(1);8-18
49. Mahata J, A. Basu, S. Ghoshal, J.N.
Sarkar, AK Roy, Poddar G, A.K. Nandy, A.
Banerjee , K. Ray, A.T. Natarajan, R.
Nilsson, A.K. Giri.Chromosomal aberrations
and sister chromatid exchanges in individuals
exposed to arsenic through drinking water in
West Bengal, India. Mut Res.2003;534:133-
143.
50. Sajeetha Beegam K.A., Sasikala K., Meenakshi
N, Calistus Jude AL, Balachandar N , Vimala
Devi M , Begum A. Asia. Ischemic Heart
Disease - A Haematological, Biochemical and
Cytogenetic Study. Int J Hum Genet.2003;
3(3): 159-163.

Thank you for copying data from http://www.arastirmax.com